Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Naltrexone Hydrochloride Tablets, 25, 50 & 100mg, Mallinckrodt, ANDA 76-264 3/22/02 4/11/03 Naltrexone Hydrochloride Tablets, 50 mg Barr ANDA 74-918 5/8/98 5/8/98 3/19/99 Naltrexone Hydrochloride Tablets USP, 50 mg, Eon Labs Manufacturing, ANDA 75-434 3/8/00 3/9/00 12/6/01 Naltrexone Hydrochloride Tablets, 50 mg Amide Pharmaceutical, ANDA 75-274 NALTREXONE HYDROCHLORIDE Tablet; 50MG NALTREXONE HCL Amide 074918 NALTREXONE HYDROCHLORIDE Tablet; 50MG NALTREXONE HCL Barr 018932 NALTREXONE HYDROCHLORIDE Tablet; 50MG REVIA Barr 075434 NALTREXONE HYDROCHLORIDE Tablet; 50MG NALTREXONE HCL Eon 076264 NALTREXONE HYDROCHLORIDE Tablet; 100MG NALTREXONE HCL Mallinckrodt 076264 NALTREXONE HYDROCHLORIDE Tablet; 25MG NALTREXONE HCL Mallinckrodt 076264 NALTREXONE HYDROCHLORIDE Tablet; 50MG NALTREXONE HCL Mallinckrodt | Vivitrol (Naltrexone) Injectable Suspension, Alkermes, Inc., Approval | VIVITROL (naltrexone) Extended-release Injectable Suspension, Alkermes Inc., Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com